Dr. Reddy's Laboratories Limited is an integrated pharmaceutical company that operates globally. Its revenue comes from four main segments: Global Generics (approximately 60%), Pharmaceutical Services and Active Ingredients (PSAI) (about 25%), Proprietary Products (around 10%), and Others (approximately 5%). The Global Generics segment includes both branded and generic pharmaceutical products, while PSAI focuses on active pharmaceutical ingredients and contract research services. Factors supporting the company's endurance include its diverse product portfolio and global presence, while challenges may arise from regulatory pressures and intense competition in the pharmaceutical industry.
—
Dr. Reddy's Laboratories Limited is an integrated pharmaceutical company that operates globally. Its revenue comes from four main segments: Global Generics (approximately 60%), Pharmaceutical Services and Active Ingredients (PSAI) (about 25%), Proprietary Products (around 10%), and Others (approximately 5%). The Global Generics segment includes both branded and generic pharmaceutical products, while PSAI focuses on active pharmaceutical ingredients and contract research services. Factors supporting the company's endurance include its diverse product portfolio and global presence, while challenges may arise from regulatory pressures and intense competition in the pharmaceutical industry.
—
Daily adjusted close
Dr. Reddy's Laboratories Limited is an integrated pharmaceutical company that operates globally. Its revenue comes from four main segments: Global Generics (approximately 60%), Pharmaceutical Services and Active Ingredients (PSAI) (about 25%), Proprietary Products (around 10%), and Others (approximately 5%). The Global Generics segment includes both branded and generic pharmaceutical products, while PSAI focuses on active pharmaceutical ingredients and contract research services. Factors supporting the company's endurance include its diverse product portfolio and global presence, while challenges may arise from regulatory pressures and intense competition in the pharmaceutical industry.